Vanessa Trump Announces 0% Recurrence After Six Months of Treatment
The former First Daughter-In-Law posted the update on Friday, citing clear test results six months after her initial April diagnosis.
By Alina Carter ·
Vanessa Trump is cancer-free.
The 48-year-old confirmed on Friday that her recent medical tests returned clear results. She shared the news in a short video posted to the Instagram account of her eldest daughter, Kai Trump. In the clip, Vanessa stated, "came back clear, so I'm finally cancer-free." This announcement marks the end of a treatment period that began in April.
Vanessa Trump first disclosed her diagnosis in May. At that time, she told followers she had undergone surgery and was collaborating with her medical team on a treatment plan. The diagnosis itself was confirmed in April, making the October update the first formal clearance since her initial public statement.
Kai Trump, 19, wrote in the Instagram caption that the video serves as a preview for a longer YouTube release scheduled for Saturday. The upcoming video features Vanessa, Kai, and Dr. Nicole Saphier discussing breast cancer awareness and prevention. Kai noted that October is Breast Cancer Awareness Month, a period dedicated to early detection and education.
The social media post generated more than 20,000 likes and hundreds of comments. American singer and media personality Mary Millben was among the supporters who left well-wishes. The engagement reflects the public interest in the former wife of Donald Trump Jr, who has five children with him.
Vanessa Trump separated from Donald Trump Jr in 2018. She announced in 2025 that she had begun a relationship with professional golfer Tiger Woods. Her health update arrives during a year when breast cancer statistics remain a focal point for health advocates.
The American Cancer Society reports that the average risk of a US woman developing breast cancer is approximately 1 in 8, or 13%. The organization states that breast cancer accounts for 30% of all new female cancers annually. Medical data indicates that surgery cures most cases of the disease. When residual disease is present, chemotherapy, radiotherapy, and endocrine therapy can reduce long-term risks. Current advancements include targeted therapies for early-stage cancer and more precise radiotherapy techniques.
